Open Orphan PLC
LSE:ORPH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Bonhill Group PLC
LSE:BONH
|
UK |
Open Orphan PLC
Other Items
Open Orphan PLC
Other Items Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Items | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
O
|
Open Orphan PLC
LSE:ORPH
|
Other Items
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Oxford Nanopore Technologies PLC
LSE:ONT
|
Other Items
£102m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Diaceutics PLC
LSE:DXRX
|
Other Items
£601k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
197%
|
CAGR 10-Years
N/A
|
|
|
G
|
Genedrive PLC
LSE:GDR
|
Other Items
£5k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-46%
|
CAGR 10-Years
-16%
|
|
|
Fusion Antibodies PLC
LSE:FAB
|
Other Items
£3k
|
CAGR 3-Years
44%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
N/A
|
|
|
hVIVO PLC
LSE:HVO
|
Other Items
-£8.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-43%
|
|
Open Orphan PLC
Glance View
Open Orphan Plc provides pharmaceutical development services. The firm is engaged in the testing of vaccines and antivirals using human clinical trials. The firm has a presence in the United Kingdom, Ireland, France and Netherlands. The Company, through its subsidiary hVIVO Limited, is also engaged in the data platform business. hVIVO Limited has built up databases of infectious disease progression data and the Company is populating its Open Orphan Health Data platform with hVIVO data. The firm also operates through its subsidiary Venn Life Sciences, which is an integrated drug development partner. Venn Life Sciences offers a combination of drug development consultancy, clinical trial design and execution to create, plan and execute drug development programs for its customers.
